George Jelinek shared some valuable information in his post - The critical part of the jigsaw of the diet in MS is Professor Swank’s work - which touched on the nature of clinical trials.
When we think of clinical trials, the image of pharma-sponsored drug trials immediately come to mind. Perhaps this is because we hear most... Read more
Yesterday and today a huge snow storm has blanketed the Washington, DC area and the East Coast. Here is just one image I took from my back door. I also shot a short video which you can view at my blog - Crazy Snow!! 2010
So when is spring supposed to arrive again?
In Monoclonal Antibodies: What Are They? we discussed a little bit about how T-cells and B-cells function within the immune system and how medications have been created to target specific antigens on those same lymphocytes. If you haven’t read it, I recommend that you read that post first and then come back to this one.
What... Read more
Late Friday afternoon, January 22, 2010, the Food and Drug Administration (FDA) announced that they approved AMPYRA™ (dalfampridine, formerly known as fampridine-SR) as a treatment to improve walking in multiple sclerosis patients. Developed by Acorda Therapeutics in partnership with Elan Corp, AMPYRA™ is a proprietary... Read more
We are now staring down the end of January. Yippee, soon we will be out of the month which is traditionally associated with "resolutions" for the year. I'm not big on resolutions since they've never really been something which motivated me in the long run. However, I am interested in making incremental changes for the... Read more